Prazosin Dosing for PTSD Nightmares
Start prazosin at 1 mg at bedtime, then increase by 1–2 mg every few days until nightmares resolve, targeting 3–4 mg/day in civilians or 9.5–15.6 mg/day in military veterans, with a maximum of 10–20 mg/day for most patients. 1
Initial Dosing Strategy
- Begin with 1 mg at bedtime to minimize first-dose orthostatic hypotension, which is the most common early adverse effect 1, 2
- Monitor blood pressure after the first dose and with each significant dose increase 1
- Use lower starting doses in elderly patients or those already taking antihypertensive medications 1
Titration Protocol
- Increase by 1–2 mg every few days based on nightmare frequency reduction and blood pressure tolerance 1, 3
- Continue titration until nightmares are adequately suppressed or the maximum recommended dose is reached 1
- Track nightmare frequency using standardized measures such as the CAPS distressing-dreams item (target score <4/8) to guide dose adjustments 2
Target Dose Ranges by Population
Civilians with PTSD
- Average effective dose: 3–4 mg/day (mean 3.1 ± 1.3 mg) 1
- Most civilian patients respond within this range in controlled trials 1
- Maintenance doses typically range from 2–6 mg at night 3
Military Veterans with Combat-Related PTSD
- Average effective dose: 9.5–15.6 mg/day 1, 3
- Veterans consistently require higher doses than civilians due to severity of combat-related trauma 1
- Gender differences exist in active-duty personnel: men require mean doses of 15.6 ± 6.0 mg while women require 7.0 ± 3.5 mg 1
Maximum Dosing
- Most patients should not exceed 10–20 mg/day, reflecting the dose range studied in clinical trials 1
- Some case reports describe safe use up to 30–45 mg/day in treatment-resistant cases, though this exceeds guideline recommendations 4
- One source suggests a maximum of 20 mg at bedtime plus 5 mg mid-morning for breakthrough daytime symptoms 5
Administration Schedule
- Initially give as a single bedtime dose for nightmare management 1
- For severe cases with daytime flashbacks, consider divided dosing (e.g., morning and bedtime doses) 1, 6
- Given prazosin's 2–3 hour half-life, three-times-daily dosing may prevent breakthrough symptoms between doses in refractory cases 6
Critical Drug Interaction
- Concurrent SSRIs or SNRIs significantly diminish prazosin's efficacy 2, 7
- In one military trial, patients on SSRIs showed only a 9.6-point CAPS improvement versus 30.1 points in those not on SSRIs 2
- In the large 2018 VA trial that showed no benefit of prazosin, 78% of participants were on maintenance antidepressants, potentially explaining the negative result 2
- Consider this interaction when deciding whether to initiate prazosin in patients already on antidepressants 2
Monitoring Parameters
- Blood pressure monitoring after initial dose and each dose escalation to detect orthostatic hypotension 1
- Nightmare frequency and intensity using sleep diaries or standardized PTSD scales 1, 2
- Dizziness and lightheadedness are common initially but usually transient 1
Important Caveats
- Nightmares return to baseline when prazosin is discontinued—this is symptomatic treatment, not curative 1, 7
- The American Academy of Sleep Medicine downgraded its recommendation after a large 2018 VA study showed no benefit over placebo, yet still affirms "many patients respond very well" and prazosin "remains the first choice for pharmacologic therapy" 2, 7
- Prazosin treats nightmare disorder with secondary benefits on PTSD symptoms; it is not a general anxiolytic 2
- Response may plateau or diminish over time in some patients 7